Judy J. Robertson has extensive experience in commercial leadership roles within the pharmaceutical and biotech industry. Judy J. has served as Chief Commercial Officer for Opthea, Eleusis, and Aerie Pharmaceuticals, overseeing the successful commercialization and strategic planning for innovative therapies. Additionally, they have held board member positions focused on commercial readiness and goal attainment. Judy's background also includes roles at Novartis, Janssen, and Bristol-Myers Squibb, where they led global business franchises and implemented strategic marketing initiatives to drive growth and profitability.
Judy J. Robertson earned an MBA in Business Administration and Management from Northwestern University - Kellogg School of Management in 2000. In 2020, they obtained certification in "The Six Morning Habits of High Performers" from LinkedIn.
January, 2022 - present
June, 2021